Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 14, 2014; 20(22): 6974-6980
Published online Jun 14, 2014. doi: 10.3748/wjg.v20.i22.6974
Published online Jun 14, 2014. doi: 10.3748/wjg.v20.i22.6974
Table 1 Comparison of expression changes in stem-cell genes in the hepatoma cell lines with different metastatic potential treated with Adriamycin (mean ± SD)
| Group | n | Wnt5b | Nanog | Sox2 |
| MHCC97-L | 3 | 31.5 ± 1.2↑ | 30.8 ± 0.2↓ | - |
| HCCLM3 | 3 | 36.7 ± 2.1↑ | 90.4 ± 0.8↓ | 6.0 ± 2.3↑ |
| t value | 6.03 | 45.40 | - | |
| P value | 0.04 | 0.00 | - |
- Citation: Sun D, Qin L, Xu Y, Liu JX, Tian LP, Qian HX. Influence of adriamycin on changes in Nanog, Oct-4, Sox2, ARID1 and Wnt5b expression in liver cancer stem cells. World J Gastroenterol 2014; 20(22): 6974-6980
- URL: https://www.wjgnet.com/1007-9327/full/v20/i22/6974.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i22.6974